Docetaxel in der First- und Second-line-Therapie des Magenkarzinoms

Publisher： Karger

E-ISSN： 2296-5262|23|6|40-42

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.6, 2004-11, pp. : 40-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Second-line-Therapie des Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 593-596

Karger

Access to resources Recommend Favorite

Irinotecan – klinischer Fortschritt in der Second-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 28-31

Karger

Access to resources Recommend Favorite

Neue Chemotherapeutika in der Therapie des fortgeschrittenen Magenkarzinoms

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Docetaxel (Taxotere®) in der First-line-Therapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Therapie des Magenkarzinoms

By  

Oncology Research and Treatment, Vol. 31, Iss. 5, 2008-11 ,pp. : 32-39

Karger

Access to resources Recommend Favorite